MYP_145233
Basic Information
Teriparatide
Hormonal / Endocrine Hormone peptide
Regulatory peptide Stimulation activity
Standard
34 amino acids
C181H291N55O51S2
Standard
Sequence
SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF
Physicochemical Analysis
4117.71 Da
8.29
0.73
0.36
0.0214
-0.67
0.64
-0.14
62.52
94.41
0.0588
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1752.65
-15.24
60.0
57.0
144.0
289.0
6.0
38.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0075870 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Parathyroid hormone analog
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Bone anabolic Osteoporosis therapeutic Parathyroid hormone receptor agonist
RECORD: Rec_0182003 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Enzyme
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Hormone replacement
RECORD: Rec_0217264 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Stimulatory
RECORD: Rec_0279822 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]; synthetic construct [Synthetic]
Parathyroid hormone
9606;32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Bone anabolic Osteoporosis therapy
Human PTH1 receptor
Clinical/Human: The half-life of teriparatide in serum is 5 min when administered by intravenous injection and approximately 1 h when administered by subcutaneous injection.